These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31787733)

  • 1. Retrospective Survey of Treatment Outcomes of Efinaconazole 10% Solution and Luliconazole 5% Solution for Onychomycosis in Our Facility.
    Shimoyama H; Kuwano Y; Sei Y
    Med Mycol J; 2019; 60(4):95-100. PubMed ID: 31787733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
    Kawai M
    Med Mycol J; 2019; 60(3):71-74. PubMed ID: 31474693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of Characteristics of Two Topical Therapeutic Agents for Onychomycosis].
    Shimamura T; Miyamae A; Imai A; Hirayanagi K; Iwanaga T; Kubota N; Shibuya K
    Med Mycol J; 2016; 57(4):J141-J147. PubMed ID: 27904059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
    Markinson B; Caldwell B
    J Am Podiatr Med Assoc; 2015 Sep; 105(5):407-11. PubMed ID: 26429609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients.
    Eichenfield LF; Elewski B; Sugarman JL; Rosen T; Vlahovic TC; Gupta AK; Stein Gold L; Pillai R; Guenin E
    J Drugs Dermatol; 2020 Sep; 19(9):867-872. PubMed ID: 33026753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
    Tschen EH; Bucko AD; Oizumi N; Kawabata H; Olin JT; Pillai R
    J Drugs Dermatol; 2013 Feb; 12(2):186-92. PubMed ID: 23377392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
    Gupta AK; Elewski BE; Sugarman JL; Ieda C; Kawabata H; Kang R; Pillai R; Olin JT; Watanabe S
    J Drugs Dermatol; 2014 Jul; 13(7):815-20. PubMed ID: 25007364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
    Watanabe S; Kishida H; Okubo A
    J Dermatol; 2017 Jul; 44(7):753-759. PubMed ID: 28332720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis.
    Gupta AK; Studholme C
    Skin Therapy Lett; 2016 Nov; 21(6):7-11. PubMed ID: 27825175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel method for predicting the efficacy of topical drugs on onychomycosis: A comparison of efinaconazole and luliconazole.
    Masumoto A; Takagi M; Sugiura K; Matsuda Y; Nakamura S; Tatsumi Y
    J Mycol Med; 2022 Aug; 32(3):101259. PubMed ID: 35255449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
    Pollak RA
    J Am Podiatr Med Assoc; 2014 Nov; 104(6):568-73. PubMed ID: 25514267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tavaborole, Efinaconazole, and Luliconazole: Three New Antimycotic Agents for the Treatment of Dermatophytic Fungi.
    Saunders J; Maki K; Koski R; Nybo SE
    J Pharm Pract; 2017 Dec; 30(6):621-630. PubMed ID: 27488125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.
    Iozumi K; Abe M; Ito Y; Uesugi T; Onoduka T; Kato I; Kato F; Kodama K; Takahashi H; Takeda O; Tomizawa K; Nomiyama T; Fujii M; Mayama J; Muramoto F; Yasuda H; Yamanaka K; Sato T; Oh-I T; Kasai H; Tsuboi R; Hattori N; Maruyama R; Omi T; Shimoyama H; Sei Y; Nakasu I; Nishimoto S; Hata Y; Mochizuki T; Fukuzawa M; Seishima M; Sugiura K; Katayama I; Yamamoto O; Shindo M; Kiryu H; Kusuhara M; Takenaka M; Watanabe S
    J Dermatol; 2019 Aug; 46(8):641-651. PubMed ID: 31206779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR; Scher RK
    Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
    Vlahovic TC; Joseph WS
    J Drugs Dermatol; 2014 Oct; 13(10):1186-90. PubMed ID: 25607552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efinaconazole 10% nail solution: a new topical treatment with broad antifungal activity for onychomycosis monotherapy.
    Gupta AK; Paquet M
    J Cutan Med Surg; 2014; 18(3):151-5. PubMed ID: 24800702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antifungal Activity of Luliconazole Nail Solution on in vitro and in vivo Onychomycosis Model].
    Shimamura T; Hasegawa N; Kubota N
    Med Mycol J; 2016; 57(1):J13-8. PubMed ID: 26936347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
    Elewski BE; Rich P; Pollak R; Pariser DM; Watanabe S; Senda H; Ieda C; Smith K; Pillai R; Ramakrishna T; Olin JT
    J Am Acad Dermatol; 2013 Apr; 68(4):600-608. PubMed ID: 23177180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis.
    Tosti A
    Cutis; 2013 Oct; 92(4):203-8. PubMed ID: 24195094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.
    Matsuda Y; Sugiura K; Hashimoto T; Ueda A; Konno Y; Tatsumi Y
    PLoS One; 2016; 11(7):e0159661. PubMed ID: 27441843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.